Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Pacific Edge Limited ( (PFGTF) ) is now available.
Pacific Edge Limited has announced a disclosure notice regarding the relevant interests of its director, Simon Flood. This announcement is part of the company’s compliance with the Financial Markets Conduct Act 2013, ensuring transparency in the financial interests of its senior management. The disclosure does not specify any changes in shareholding or derivatives, indicating a stable position for the director within the company.
More about Pacific Edge Limited
Pacific Edge Limited operates in the biotechnology industry, focusing on the development and commercialization of diagnostic tests for the early detection and management of cancer. The company is known for its innovative solutions in the healthcare sector, primarily targeting the oncology market.
For an in-depth examination of PFGTF stock, go to TipRanks’ Overview page.